Clinical Trials Logo

Filter by:
NCT ID: NCT04232501 Withdrawn - Clinical trials for Deep Venous Thrombosis

Radial, Sequential Compression Device Deep Venous Thrombosis Detection Study

Start date: January 8, 2021
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the effectiveness of a new leg compression device in preventing post-surgical deep vein thrombosis (blood clot) that can occur after major and complex spine surgery. The investigators aim to show that this new compression device is no worse than the standard sequential compression device (SCD) at preventing DVT and may be able to detect deep vein thrombosis in patients who are not typically screened for this diagnosis after surgery. This new device may be able to capture an important post-surgical complication while providing a more comfortable treatment option.

NCT ID: NCT04232319 Withdrawn - Breast Cancer Clinical Trials

Feasibility and Effectiveness of a Sleep Hygiene Education Program for Sleep Issues in Breast Cancer Survivors

Start date: January 15, 2020
Phase: N/A
Study type: Interventional

The proposed research will assess the feasibility and preliminary effectiveness of a Sleep Hygiene Program for Breast Cancer Survivors. Participants will complete assessments related to sleep issues, participate in a Sleep Hygiene Program, and complete another assessment post-intervention.

NCT ID: NCT04232306 Withdrawn - Postoperative Pain Clinical Trials

Liposomal Bupivacaine + Bupivacaine vs. Bupivacaine Alone on Opioid Use After Elective c/Section

Start date: March 2024
Phase: Phase 4
Study type: Interventional

The purpose of this study is to compare the effectiveness of local wound infiltration of EXPAREL® (liposomal bupivacaine) with bupivacaine HCl compared to active control with bupivacaine HCl alone following elective primary or repeat cesarean delivery with spinal anesthesia.

NCT ID: NCT04231734 Withdrawn - Clinical trials for Mantle Cell Lymphoma

Ketogenic Diet in Patients With Untreated Low Tumor Burden Mantle Cell Lymphoma

Start date: April 2023
Phase: N/A
Study type: Interventional

This study evaluates adherence to a ketogenic diet in patients with low tumor burden, treatment-naïve mantle cell lymphoma.

NCT ID: NCT04230720 Withdrawn - Cataract Clinical Trials

Effect of Artificial Tears on Biometry

Start date: April 2021
Phase: Phase 4
Study type: Interventional

The purpose of this study is to determine if measurements for cataract surgery are improved with use of additional lubrication with artificial tears. The research study is being done to optimize measurements and provide patients with the best visual outcomes after cataract surgery.

NCT ID: NCT04230031 Withdrawn - Multiple Myeloma Clinical Trials

Phase II Study of Daratumumab Pre-Mobilization and Post-ASCT in Multiple Myeloma

Start date: July 2, 2021
Phase: Phase 2
Study type: Interventional

This study will use the drug daratumumab in patients who did not achieve at least a very good partial response (VGPR) and are already planned to have an Autologous Stem Cell Transplant (ASCT). Daratumumab will be given before the stem cell collection to attempt to get rid of any multiple myeloma cells that may be present in the stem cell collection and after the ASCT to get rid of any multiple myeloma cells that may be remaining.

NCT ID: NCT04228666 Withdrawn - Alzheimer Disease Clinical Trials

A Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Autologous Mesenchymal Stem Cell Therapy (HB-adMSCs) for the Treatment of Alzheimer's Disease

Start date: March 1, 2020
Phase: Phase 1/Phase 2
Study type: Interventional

Hope Biosciences is conducting a research study of an investigational product called autologous adipose-derived mesenchymal stem cells (abbreviated as HB-adMSCs) as a possible treatment for Alzheimer's disease (AD). The study purpose is to evaluate the safety profile of four IV infusions of HB-adMSCs in subjects with clinical diagnosis of AD.

NCT ID: NCT04228003 Withdrawn - Type2 Diabetes Clinical Trials

Pendulum D2D Glucose Control for Adults With Type 2 Diabetes

Start date: January 15, 2021
Phase: N/A
Study type: Interventional

The study is a single site, prospective, open label, observational, single arm trial in 30 patients with type 2 diabetes with GI complaints using 1 or more oral or injectable anti-hyperglycemic agents to investigate if altering the microbiome though Pendulum T2D dietary supplementation can further enhance the efficacy of the current treatment while reducing the GI associated symptoms in patients with Type 2 diabetes.

NCT ID: NCT04227626 Withdrawn - Type 1 Diabetes Clinical Trials

Inpatient Closed Loop Glucose Control With the Gen 2 GlucoSTAT

Start date: April 2021
Phase: N/A
Study type: Interventional

The goal of this study is to perform a first-in-humans trial of a fully integrated, automated, closed-loop blood glucose control system designed for inpatient use. The GlucoSTAT was designed for use by patients with diabetes while they are in the hospital, and others who may develop high blood sugar as a result of their medical problems.

NCT ID: NCT04225299 Withdrawn - Clinical trials for Localized Prostate Cancer

Evaluation of Efficacy of TOOKAD® (VTP) Versus Active Surveillance for Intermediate Risk Localized Prostate Cancer

Start date: March 31, 2020
Phase: Phase 3
Study type: Interventional

Multi-center, prospective, randomized controlled clinical trial that will compare two treatment methods (PGA with TOOKAD® VTP and Active Surveillance) for treating localized prostate cancer. The study will include criteria for evaluation, biopsy, eligibility, informed consent, subsequent management and decision making conducted based on data provided locally at each center that follow a set of standardized criteria.